Balaji Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 31-07-2024
- Paid Up Capital ₹ 1.03 Cr
as on 31-07-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.76 Cr
as on 31-07-2024
- Revenue 26.89%
(FY 2023)
- Profit 71.83%
(FY 2023)
- Ebitda 105.37%
(FY 2023)
- Net Worth 17.51%
(FY 2023)
- Total Assets 162.19%
(FY 2023)
About Balaji Agri Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.03 Cr.
The company currently has active open charges totaling ₹4.76 Cr.
Deepak Kumar and Alok Agrawal serve as directors at the Company.
- CIN/LLPIN
U01407OR2012PTC014908
- Company No.
014908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bargarh, Orissa, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Balaji Agri Biotech Private Limited offer?
Balaji Agri Biotech Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Hybrid Seeds.
Who are the key members and board of directors at Balaji Agri Biotech?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepak Kumar | Director | 07-Feb-2012 | Current |
Alok Agrawal | Director | 13-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Balaji Agri Biotech.
Balaji Agri Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.89% increase. The company also saw a substantial improvement in profitability, with a 71.83% increase in profit. The company's net worth Soared by an impressive increase of 17.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Balaji Agri Biotech?
In 2023, Balaji Agri Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sevi Spirits And Beverage India Private Limited
Active 12 years 9 monthsDeepak Kumar is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 18 Jun 2018 | ₹4.76 Cr | Open |
How Many Employees Work at Balaji Agri Biotech?
Balaji Agri Biotech has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balaji Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaji Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.